Harmonic Discovery develops an integrated computational and experimental platform to enable kinase drug discovery and targeted polypharmacology. Its models span atomic and bond topology, three‑dimensional kinase structure, and dynamic cellular disease environments to design safer, more efficacious kinase therapeutics. The platform combines systems biology, cheminformatics, medicinal chemistry, and machine learning to generate novel therapies across indications such as cancer and autoimmune disorders. Founded in 2021 by Rayees Rahman, Jason Lee, and Marcel Patek, the company is a resident of JLABS @ NYC. It plans to use the seed funding to advance its discovery platform and pipeline by expanding its leadership team, building proprietary chemical libraries, and scaling laboratory operations. The company launched with $8 million in seed financing to support those efforts.

Total raised

$8M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2022